Emma Mohr, MD, PhD, was recently awarded a Critical Life Supplement from the National Institutes of Health/National Institute of Allergy & Infectious Diseases (NIH/NIAID) to her mentored clinical scientist research career development award (K08 AI139341). This supplement provides $50,183 in funding to support additional staff to assist her in achieving the goals of her research project, “Defining Maternal and Neonatal Antibody Responses in Congenital Zika Virus Infection,” which aims to define the relationship between the antibody response during congenital Zika infection and outcomes of infection.